NR3C2 and neoplasm: TLR2, TLR4, and inflammasome inducing MR, NLRP3 [66] can lead to tumor progression via the production of inflammatory cytokines (IL6, IL16), increased cell proliferation, and resistance to apoptosis (TNFAIP3) [66, 67].